VistaPath Biosystems
About:
VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, inking, and measuring tissues.
Website: https://www.vistapath.ai
Twitter/X: VistaPathBio
Top Investors: NextGen Venture Partners, Cota Capital, First Star Ventures, Moxxie Ventures, MIT Venture Mentoring Service (MIT VMS)
Description:
VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, describing, inking, and measuring tissues that are to be processed for diagnosis. The company's platform automatically locates, measure and image tissue as it's placed into the cassette, eliminate mix-ups and errors, visualize specimens and easily see and react to changes in workload, enabling pathologists to prepare samples for diagnosis automatically and reduce errors involved with the process.
$8.91M
$1M to $10M
Cambridge, Massachusetts, United States
2017-01-01
info(AT)vistapathbio.com
Ben Burley, Timothy Spong
11-50
2024-06-21
Private
© 2025 bioDAO.ai